JP2006504787A5 - - Google Patents

Download PDF

Info

Publication number
JP2006504787A5
JP2006504787A5 JP2004550230A JP2004550230A JP2006504787A5 JP 2006504787 A5 JP2006504787 A5 JP 2006504787A5 JP 2004550230 A JP2004550230 A JP 2004550230A JP 2004550230 A JP2004550230 A JP 2004550230A JP 2006504787 A5 JP2006504787 A5 JP 2006504787A5
Authority
JP
Japan
Prior art keywords
composition
group
artemisinin
endoperoxide
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004550230A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006504787A (ja
JP4594734B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/034431 external-priority patent/WO2004041176A2/en
Publication of JP2006504787A publication Critical patent/JP2006504787A/ja
Publication of JP2006504787A5 publication Critical patent/JP2006504787A5/ja
Application granted granted Critical
Publication of JP4594734B2 publication Critical patent/JP4594734B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004550230A 2002-10-31 2003-10-29 C型肝炎、牛ウイルス性下痢症及び豚コレラウイルスを含むフラビウイルス科ウイルスにより生起される感染症の治療のためのエンドペルオキシド類の使用 Expired - Fee Related JP4594734B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42268302P 2002-10-31 2002-10-31
PCT/US2003/034431 WO2004041176A2 (en) 2002-10-31 2003-10-29 The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus

Publications (3)

Publication Number Publication Date
JP2006504787A JP2006504787A (ja) 2006-02-09
JP2006504787A5 true JP2006504787A5 (https=) 2006-09-14
JP4594734B2 JP4594734B2 (ja) 2010-12-08

Family

ID=32312544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004550230A Expired - Fee Related JP4594734B2 (ja) 2002-10-31 2003-10-29 C型肝炎、牛ウイルス性下痢症及び豚コレラウイルスを含むフラビウイルス科ウイルスにより生起される感染症の治療のためのエンドペルオキシド類の使用

Country Status (11)

Country Link
US (1) US7842719B2 (https=)
EP (1) EP1585524B1 (https=)
JP (1) JP4594734B2 (https=)
CN (1) CN100430061C (https=)
AT (1) ATE473745T1 (https=)
AU (1) AU2003287259A1 (https=)
CA (1) CA2501584C (https=)
DE (1) DE60333392D1 (https=)
ES (1) ES2348536T3 (https=)
PT (1) PT1585524E (https=)
WO (1) WO2004041176A2 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3257509A1 (en) 2003-02-12 2017-12-20 Georgetown University Use of artemisinin and related compounds for treating anorectal squamous cell cancer induced by human papilloma virus
ES2245248B1 (es) * 2004-06-09 2007-02-16 Universidad De Salamanca Uso de la artemisinina y sus derivados en la fabricacion de medicamentos utiles como agentes antiviricos.
KR100824106B1 (ko) * 2006-05-30 2008-04-21 주식회사 씨티씨바이오 흰반점바이러스를 치료 또는 예방하기 위한 조성물 및 방법
WO2008010620A1 (en) * 2006-07-21 2008-01-24 Ben's Lab Co., Ltd. Composition comprising the crude drug extracts for improving liver function
BRPI0715714A2 (pt) * 2006-08-25 2014-03-11 Wyeth Corp Métodos para diminuir a frequência de emergência de uma infecção viral de hepatite c resistente ao tratamento, para atrasar a emergência de uma infecção viral de hepatite c resistente ao tratamento, para diminuir o nível de resistência de uma infecção viral de hepatite c resistente ao tratamento, para diminuir a emergência de uma infecção viral de hepatite c resistente a hcv-796, para identificar um indivíduo com uma probabilidade diminuída de responder a uma terapia viral anti-hepatite c, para monitorar, diagnosticar ou prognosticar a infecção viral de hepatite c resistente ao tratamento em um paciente, para monitorar o curso de tratamento de uma infecção viral de hepatite c em um paciente, para prognosticar o desenvolvimento de um ainfecção viral de hepatite c resistente ao tratamento em um paciente, para monitorar a infecção viral de hepatite c em um paciente e para diagnosticar o desenvolvimento de uma infecção viral de hepatite ao tratamento em um paciente
EP2310393A4 (en) * 2008-06-17 2011-06-22 Hhv 6 Foundation ARTEMISININE AND DERIVATIVES THEREOF AS ANTIVIRAL AGENTS
CN102731464B (zh) * 2011-04-12 2014-07-23 沈阳药科大学 一个倍半萜内酯化合物、制备方法及其应用
US20130012470A1 (en) * 2011-07-07 2013-01-10 Humanitas Technology, LLC Antiviral compositions and methods of their use
US20130028882A1 (en) 2011-07-07 2013-01-31 Humanitas Technology, LLC Antiviral compositions and methods of their use
BR112014026158A2 (pt) * 2012-04-18 2017-06-27 Hadasit Med Res Service métodos e composições para o tratamento de infecções virais
FR2989588A1 (fr) * 2012-04-19 2013-10-25 Centre Nat Rech Scient Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae
CN102755316A (zh) * 2012-07-16 2012-10-31 中国科学院武汉病毒研究所 青蒿素及其衍生物在制备治疗丙型肝炎病毒药物中的应用
CN110139655A (zh) * 2016-10-07 2019-08-16 纳维迪亚生物制药有限公司 诊断和治疗病毒性感染的化合物和方法
GB201805665D0 (en) * 2018-04-05 2018-05-23 Univ Nottingham Antiviral Compounds And Methods
WO2019232129A1 (en) * 2018-05-30 2019-12-05 The Board Of Regents Of The University Of Texas System Treatment of viral infections and virally associated lesions with sequiterpene lactones
WO2021216385A1 (en) * 2020-04-20 2021-10-28 Tran Lloyd Hung Loi Methods for the prophylaxis and treatment of covid and covid-19
CN112245424B (zh) * 2020-10-19 2021-09-21 中国医学科学院医药生物技术研究所 一种没药烷倍半萜结构类似物在制备抗冠状病毒药物中的用途
CN112294795B (zh) * 2020-11-17 2022-03-29 北京化工大学 蒿甲醚在治疗和预防柯萨奇病毒感染中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW198722B (https=) 1990-05-07 1993-01-21 Hoechst Ag
CN1058717A (zh) * 1990-08-08 1992-02-19 中国人民解放军军事医学科学院微生物流行病研究所 抗疟新药—复方蒿甲醚及其制备方法
CN1035767C (zh) * 1992-11-10 1997-09-03 罗宣德 新的青蒿素衍生物及其用途
CN1105238A (zh) * 1992-11-10 1995-07-19 中国预防医学科学院病毒学研究所 抗aids病毒的药物组合物
US5726203A (en) * 1993-07-19 1998-03-10 Li; Zelin Qinghaosu derivatives against AIDS
DE4415539C2 (de) * 1994-05-03 1996-08-01 Osama Dr Dr Med Omer Pflanzen mit virustatischer und antiviraler Wirkung
CN1049435C (zh) * 1994-11-09 2000-02-16 中国科学院上海药物研究所 含苯基和杂环基的青蒿素衍生物及其制备方法
DE19902924A1 (de) 1999-01-26 2000-08-03 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen
CN1135974C (zh) 2000-08-23 2004-01-28 重庆健桥医药开发有限公司 抗疟药新药复方双氢青蒿素
AU2001295979A1 (en) 2000-10-20 2002-04-29 Ajinomoto Co., Inc. Medicinal compositions, dose and method for treating malaria
EP3257509A1 (en) * 2003-02-12 2017-12-20 Georgetown University Use of artemisinin and related compounds for treating anorectal squamous cell cancer induced by human papilloma virus

Similar Documents

Publication Publication Date Title
JP2006504787A5 (https=)
JP2002060340A5 (https=)
JP2004509061A5 (https=)
DE60131250T8 (de) Nucleosid-analoga mit monozyklischen basischen carboxamidingruppen
JP2009511595A5 (https=)
JP2004534769A5 (https=)
JP2010503396A5 (https=)
JP2008505985A5 (https=)
JP2007513971A5 (https=)
CA2413163A1 (en) 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides
JP2010529835A5 (https=)
JP2003503454A5 (https=)
JP2003526662A5 (https=)
JP2007531741A5 (https=)
JP2007508234A5 (https=)
JP2005506087A5 (https=)
JP2006526031A5 (https=)
EP2277505A3 (en) Mucoactive agents for treating a pulmonary disease
JP2011507972A5 (https=)
JP2006506097A5 (https=)
JP4594734B2 (ja) C型肝炎、牛ウイルス性下痢症及び豚コレラウイルスを含むフラビウイルス科ウイルスにより生起される感染症の治療のためのエンドペルオキシド類の使用
JP2004509837A5 (https=)
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
JP2005533800A5 (https=)
WO2002072802A3 (en) Live attenuated strains of prrs virus